Literature DB >> 18480937

Efficacy of interleukin 1 receptor antagonist (anakinra) on a refractory case of Schnitzler's syndrome.

Nicolas Kluger, Sophie Rivière, Bernard Guillot, Didier Bessis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18480937     DOI： 10.2340/00015555-0404

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  6 in total

Review 1.  Autoinflammation: From monogenic syndromes to common skin diseases.

Authors:  Tien V Nguyen; Edward W Cowen; Kieron S Leslie
Journal:  J Am Acad Dermatol       Date:  2013-02-28       Impact factor: 11.527

2.  Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome.

Authors:  Dorota M Rowczenio; Shelly Pathak; Juan I Arostegui; Anna Mensa-Vilaro; Ebun Omoyinmi; Paul Brogan; Dan Lipsker; Thomas Scambler; Roger Owen; Hadija Trojer; Anna Baginska; Julian D Gillmore; Ashutosh D Wechalekar; Thirusha Lane; Rene Williams; Taryn Youngstein; Philip N Hawkins; Sinisa Savic; Helen J Lachmann
Journal:  Blood       Date:  2017-12-28       Impact factor: 22.113

3.  [IL-1 antagonists].

Authors:  I Kötter; G Horneff
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

4.  Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler's syndrome: a case report and literature review.

Authors:  Emilio Besada; Hans Nossent
Journal:  Clin Rheumatol       Date:  2010-02-01       Impact factor: 3.650

Review 5.  Schnitzler's syndrome: lessons from 281 cases.

Authors:  Heleen D de Koning
Journal:  Clin Transl Allergy       Date:  2014-12-05       Impact factor: 5.871

6.  Schnitzler's syndrome - a novel hypothesis of a shared pathophysiologic mechanism with Waldenström's disease.

Authors:  F S van Leersum; J Potjewijd; M van Geel; P M Steijlen; M Vreeburg
Journal:  Orphanet J Rare Dis       Date:  2019-06-22       Impact factor: 4.123
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.